DBV Technologies SA at Goldman Sachs Global Healthcare Conference Transcript
Okay, good morning, everyone, and welcome to I believe it's the 8:40 session here at the Goldman Sachs Global Healthcare Conference. By introduction, my name is Graig Suvannavejh; I cover European biotech for the Firm and I'm seated out of London. It's my pleasure to introduce DBV Technologies today. With us is CEO Daniel Tassé and in the audience is Sara Sherman who is Senior Director of Investor Relations.
Questions & Answers
So with that, Daniel, you are new to the company, CEO. Maybe if you could just tell us your thought process when you were thinking about opportunities, why DBV was the one that you were compelled to join.
©,-
Thank you and good morning, Graig. Look, I'm the poster child for the traditional pharmaceutical industry with a graduate degree in biochemistry, then took on commercial jobs and then after that strategy in jobs that intersect science
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |